Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Hans Brunnstr??m
Affiliation
Lund University
ORCID
Career Start Year
1977
Papers
112
H Index
29
Expertise
CM4AI Collaborator
Emma Lundberg (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37801008
Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma.
Mol Cancer Res
2024
34429353
Reference standards for gene fusion molecular assays on cytological samples: an international validation study.
J Clin Pathol
2023
37897706
Real-world analysis of MET exon 14 mutations in non-small cell lung cancer: a retrospective study from two Swedish hospitals.
Acta Oncol
2023
36958084
Pulmonary 5-HT<sub>2B</sub> receptor expression in fibrotic interstitial lung diseases.
Acta Histochem
2023
37255692
Treatment refractory arthritis and stroke - A case of infective endocarditis caused by <i>Tropheryma whipplei</i>.
IDCases
2023
37349623
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases.
Virchows Arch
2023
37341056
Expression of cancer-testis antigens in the immune microenvironment of non-small cell lung cancer.
Mol Oncol
2023
37337638
Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma.
Cytopathology
2023
36963351
Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer.
Eur J Cancer
2023
36824691
Aggrecan accumulates at sites of increased pulmonary arterial pressure in idiopathic pulmonary arterial hypertension.
Pulm Circ
2023
36083003
Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features.
J Natl Cancer Inst
2023
35108331
Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC-A retrospective single-center experience.
PLoS One
2022
35725677
Interventional and EBUS cytology in Sweden.
Semin Diagn Pathol
2022
35562908
PD-L1 Expression in Non-Small Cell Lung Cancer Specimens: Association with Clinicopathological Factors and Molecular Alterations.
Int J Mol Sci
2022
36636421
Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas.
Transl Lung Cancer Res
2022
35915169
Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer.
Nat Genet
2022
33547095
Difficulties in diagnostics of lung tumours in biopsies: an interpathologist concordance study evaluating the international diagnostic guidelines.
J Clin Pathol
2022
33676904
Intraoperative Cytology for Video-Assisted Thoracic Surgery: A Quality Improvement Analysis.
Ann Thorac Surg
2022
35326483
Ciliated (FOXJ1<sup>+</sup>) Cells Display Reduced Ferritin Light Chain in the Airways of Idiopathic Pulmonary Fibrosis Patients.
Cells
2022
35138370
Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk.
Hum Mol Genet
2022
32924180
Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer.
Genet Epidemiol
2021
33576873
PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung.
Cancer Immunol Immunother
2021
33881927
Distinct types of plexiform lesions identified by synchrotron-based phase-contrast micro-CT.
Am J Physiol Lung Cell Mol Physiol
2021
33493383
Higher concordance of PD-L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma.
Cancer Cytopathol
2021
33706249
The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types.
EBioMedicine
2021
33667223
Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers.
PLoS Genet
2021
33497473
Clinical significance of RBM3 expression in surgically treated colorectal lung metastases and paired primary tumors.
J Surg Oncol
2021
34870237
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms.
Nat Cancer
2021
34617060
Resolving the biological paradox of aneurysm formation in children with tuberous sclerosis complex.
JVS Vasc Sci
2021
34789779
TGF-β-mediated epithelial-mesenchymal transition and tumor-promoting effects in CMT64 cells are reflected in the transcriptomic signature of human lung adenocarcinoma.
Sci Rep
2021
34679625
Factors Influencing Concordance of PD-L1 Expression between Biopsies and Cytological Specimens in Non-Small Cell Lung Cancer.
Diagnostics (Basel)
2021
33984662
FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response.
Eur J Cancer
2021
34339045
Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer.
J Pathol
2021
34233336
PD-L1 Testing in Cytological Non-Small Cell Lung Cancer Specimens: A Comparison with Biopsies and Review of the Literature.
Acta Cytol
2021
34111430
Protein Signatures of Remodeled Airways in Transplanted Lungs with Bronchiolitis Obliterans Syndrome Obtained Using Laser-Capture Microdissection.
Am J Pathol
2021
33310622
Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer.
Lung Cancer
2021
32889700
Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma.
Front Med
2021
32745259
A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis.
Int J Cancer
2021
32914876
Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization.
Int J Cancer
2021
31596108
Synchrotron-based phase-contrast micro-CT as a tool for understanding pulmonary vascular pathobiology and the 3-D microanatomy of alveolar capillary dysplasia.
Am J Physiol Lung Cell Mol Physiol
2020
34589915
Clinical Utility of Targeted Sequencing in Lung Cancer: Experience From an Autonomous Swedish Health Care Center.
JTO Clin Res Rep
2020
32028050
WITHDRAWN: Characterization of Patterns of Immune Cell Infiltration in NSCLC.
J Thorac Oncol
2020
31696517
Transcriptome-wide association study reveals candidate causal genes for lung cancer.
Int J Cancer
2020
31913660
Diagnostic Value of Insulinoma-Associated Protein 1 (INSM1) and Comparison With Established Neuroendocrine Markers in Pulmonary Cancers.
Arch Pathol Lab Med
2020
33126877
A new efficient method to detect genetic interactions for lung cancer GWAS.
BMC Med Genomics
2020
32737190
Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe.
J Clin Pathol
2020
32707835
Methylation Patterns and Chromatin Accessibility in Neuroendocrine Lung Cancer.
Cancers (Basel)
2020
32277007
Association Analysis of Driver Gene-Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls.
Cancer Epidemiol Biomarkers Prev
2020
32145220
Typical and atypical carcinoid tumors of the lung: a clinicopathological correlation of 783 cases with emphasis on histological features.
Hum Pathol
2020
32238062
Immune checkpoint inhibitors of the PD-1/PD-L1-axis in non-small cell lung cancer: promise, controversies and ambiguities in the novel treatment paradigm.
Scand J Clin Lab Invest
2020
1 - 50 of 112
Column Actions
Search
Recommended Authors
Daniel Kazdal
Institut fur Pathologie, Universitatsklinikum Heidelberg
Career Start Year
2016
Number of shared co-authors
0
Philipp Jurmeister
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year
2015
Number of shared co-authors
1
Mich??le Orain
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Career Start Year
2013
Number of shared co-authors
5
Nazim Benzerdjeb
Institut de Pathologie Multisite
Career Start Year
2013
Number of shared co-authors
1
David A Moore
University College London Cancer Institute
Career Start Year
2012
Number of shared co-authors
0
Zhixin Qiu
UPMC Hillman Cancer Center
Career Start Year
2012
Number of shared co-authors
0
Fei Li
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Career Start Year
2010
Number of shared co-authors
0
Shingo Sakashita
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Career Start Year
2008
Number of shared co-authors
3
Martina Kirchner
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2007
Number of shared co-authors
0
Shirin Karimi
Princess Margaret Cancer Centre
Career Start Year
2006
Number of shared co-authors
0
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2005
Number of shared co-authors
33
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2005
Number of shared co-authors
8
Hye Ryun Kim
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year
2005
Number of shared co-authors
0
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year
2004
Number of shared co-authors
3
Marzena Walkiewicz
Olivia Newton-John Cancer Research Institute
Career Start Year
2003
Number of shared co-authors
1
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year
2002
Number of shared co-authors
6
Xin Yang
Peking University Cancer Hospital & Institute
Career Start Year
2002
Number of shared co-authors
1
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2001
Number of shared co-authors
1
Naoki Yanagawa
Yamagata Prefectural Central Hospital
Career Start Year
1998
Number of shared co-authors
3
Nan Wu
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Career Start Year
1997
Number of shared co-authors
0
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year
1997
Number of shared co-authors
4
Prudence A Russell
St Vincent's Hospital
Career Start Year
1997
Number of shared co-authors
2
Anthony J Iafrate
Massachusetts General Hospital
Career Start Year
1997
Number of shared co-authors
7
Jorge Nieva
Norris Comprehensive Cancer Center, University of Southern California
Career Start Year
1995
Number of shared co-authors
2
Pierre P Massion
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year
1993
Number of shared co-authors
6
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Career Start Year
1991
Number of shared co-authors
0
Martine Antoine
Erasme University Hospital, Universite Libre de Bruxelles
Career Start Year
1989
Number of shared co-authors
0
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year
1988
Number of shared co-authors
18
David M Jablons
University of California, USA Cardiovascular Research Institute san francisco
Career Start Year
1981
Number of shared co-authors
2
David L Rimm
Yale University School of Medicine
Career Start Year
1980
Number of shared co-authors
13
row(s) 1 - 30 of 30
Collaborators
Patrick Micke
Uppsala University
Co-authored papers
34
Johanna S M Mattsson
Uppsala University
Co-authored papers
25
Loic Le Marchand
Co-authored papers
22
Neil E Caporaso
National Cancer Institute, National Institutes of Health
Co-authored papers
22
Demetrius Albanes
Co-authored papers
21
Christopher I Amos
Baylor College of Medicine
Co-authored papers
21
Lambertus A Kiemeney
Co-authored papers
20
Angela Risch
Allergy-Cancer-BioNano Research Centre, University of Salzburg
Co-authored papers
20
Geoffrey Liu
The Princess Margaret Cancer Centre/University of Toronto
Co-authored papers
20
Karin Jirstr??m
Lund University
Co-authored papers
20
Heike Bickeb??ller
University Medical Center Goettingen
Co-authored papers
20
John K Field
University of Liverpool, Molecular & Clinical Cancer Medicine
Co-authored papers
18
Maria Teresa Landi
National Cancer Institute
Co-authored papers
18
Olle Melander
Co-authored papers
18
H-Erich Wichmann
Co-authored papers
16
Rayjean J Hung
Lunenfeld-Tanenbaum Research Institute
Co-authored papers
15
Younghun Han
Institute for Clinical and Translational Research, Baylor College of Medicine
Co-authored papers
11
Dijana Djureinovic
Yale University School of Medicine
Co-authored papers
11
Xiangjun Xiao
Institute for Clinical and Translational Research, Baylor College of Medicine
Co-authored papers
10
Cecilia Lindskog
Uppsala University
Co-authored papers
9
Fredrik Pont??n
Uppsala University
Co-authored papers
9
Albert Rosenberger
University of Goettingen
Co-authored papers
8
Jennifer A Doherty
Huntsman Cancer Institute, University of Utah
Co-authored papers
7
Jinyoung Byun
Institute for Clinical and Translational Research, Baylor College of Medicine
Co-authored papers
7
Yafang Li
University of Michigan ann arbor
Co-authored papers
7
Jolanta Lissowska
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers
7
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers
7
Dakai Zhu
The Institute for Clinical and Translational Research, Baylor College of Medicine
Co-authored papers
7
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers
7
Christopher A Haiman
University of Southern California
Co-authored papers
7
1 - 30